Supporting this, both constitutive deletion of the GATA2+9.5 enhancer (strongly active in developing embryonic ECs)72 and endothelial‐specific deletions of Gata2 result in lethality at E13–16.5 with vascular abnormalities including hemorrhage, edema, and anemia. The gene discussed is GATA2; the disease is anemia.